Karina Cuevas-Mora1, Willy Roque2, Hoora Shaghaghi1, Bernadette R Gochuico3, Ivan O Rosas4, Ross Summer5, Freddy Romero6. 1. Department of Medicine, Division of Pulmonary, Allergy and Critical Care and the Center for Translational Medicine, The Jane & Leonard Korman Respiratory Institute, Philadelphia, PA, USA. 2. Department of Medicine, Rutgers - New Jersey Medical School, 185 S Orange Ave, Newark, NJ, 07103, USA. 3. Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA. 4. Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX, USA. 5. Department of Medicine, Division of Pulmonary, Allergy and Critical Care and the Center for Translational Medicine, The Jane & Leonard Korman Respiratory Institute, Philadelphia, PA, USA. Ross.Summer@Jefferson.edu. 6. Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX, USA. Freddy.RomeroVasquez@bcm.edu.
Abstract
BACKGROUND: Mitochondrial dysfunction has emerged as an important player in the pathogenesis of idiopathic pulmonary fibrosis (IPF), a common cause of idiopathic interstitial lung disease in adults. Hermansky-Pudlak syndrome (HPS) is a rare autosomal recessive disorder that causes a similar type of pulmonary fibrosis in younger adults, although the role of mitochondrial dysfunction in this condition is not understood. METHODS: We performed a detailed characterization of mitochondrial structure and function in lung tissues and alveolar epithelial cells deficient in the adaptor protein complex 3 beta 1 (Ap3b1) subunit, the gene responsible for causing subtype 2 of HPS (HPS-2). RESULTS: We observed widespread changes in mitochondrial homeostasis in HPS-2 cells, including the acquisition of abnormally shaped mitochondria, with reduced number of cristae, and markedly reduced activity of the electron transport chain and the tricarboxylic acid cycle. We also found that mitochondrial redox imbalance and activity of the mitochondrial unfolded protein response were dysregulated in HPS-2 cells and this associated with various other changes that appeared to be compensatory to mitochondrial dysfunction. This included an increase in glycolytic activity, an upregulation in the expression of mitochondrial biogenesis factors and enhanced activation of the energy-conserving enzyme AMP-activated protein kinase. CONCLUSION: In summary, our findings indicate that mitochondrial function is dramatically altered in HPS-2 lung tissues, suggesting dysfunction of this organelle might be a driver of HPS lung disease.
BACKGROUND: Mitochondrial dysfunction has emerged as an important player in the pathogenesis of idiopathic pulmonary fibrosis (IPF), a common cause of idiopathic interstitial lung disease in adults. Hermansky-Pudlak syndrome (HPS) is a rare autosomal recessive disorder that causes a similar type of pulmonary fibrosis in younger adults, although the role of mitochondrial dysfunction in this condition is not understood. METHODS: We performed a detailed characterization of mitochondrial structure and function in lung tissues and alveolar epithelial cells deficient in the adaptor protein complex 3 beta 1 (Ap3b1) subunit, the gene responsible for causing subtype 2 of HPS (HPS-2). RESULTS: We observed widespread changes in mitochondrial homeostasis in HPS-2 cells, including the acquisition of abnormally shaped mitochondria, with reduced number of cristae, and markedly reduced activity of the electron transport chain and the tricarboxylic acid cycle. We also found that mitochondrial redox imbalance and activity of the mitochondrial unfolded protein response were dysregulated in HPS-2 cells and this associated with various other changes that appeared to be compensatory to mitochondrial dysfunction. This included an increase in glycolytic activity, an upregulation in the expression of mitochondrial biogenesis factors and enhanced activation of the energy-conserving enzyme AMP-activated protein kinase. CONCLUSION: In summary, our findings indicate that mitochondrial function is dramatically altered in HPS-2 lung tissues, suggesting dysfunction of this organelle might be a driver of HPS lung disease.
Authors: Louise Hecker; Naomi J Logsdon; Deepali Kurundkar; Ashish Kurundkar; Karen Bernard; Thomas Hock; Eric Meldrum; Yan Y Sanders; Victor J Thannickal Journal: Sci Transl Med Date: 2014-04-09 Impact factor: 17.956
Authors: Seunghyi Kook; Aidong Qi; Ping Wang; Shufang Meng; Peter Gulleman; Lisa R Young; Susan H Guttentag Journal: Am J Respir Cell Mol Biol Date: 2018-05 Impact factor: 6.914
Authors: Luca Richeldi; Roland M du Bois; Ganesh Raghu; Arata Azuma; Kevin K Brown; Ulrich Costabel; Vincent Cottin; Kevin R Flaherty; David M Hansell; Yoshikazu Inoue; Dong Soon Kim; Martin Kolb; Andrew G Nicholson; Paul W Noble; Moisés Selman; Hiroyuki Taniguchi; Michèle Brun; Florence Le Maulf; Mannaïg Girard; Susanne Stowasser; Rozsa Schlenker-Herceg; Bernd Disse; Harold R Collard Journal: N Engl J Med Date: 2014-05-18 Impact factor: 91.245
Authors: Guoying Yu; Argyris Tzouvelekis; Rong Wang; Jose D Herazo-Maya; Gabriel H Ibarra; Anup Srivastava; Joao Pedro Werneck de Castro; Giuseppe DeIuliis; Farida Ahangari; Tony Woolard; Nachelle Aurelien; Rafael Arrojo E Drigo; Ye Gan; Morven Graham; Xinran Liu; Robert J Homer; Thomas S Scanlan; Praveen Mannam; Patty J Lee; Erica L Herzog; Antonio C Bianco; Naftali Kaminski Journal: Nat Med Date: 2017-12-04 Impact factor: 53.440
Authors: Souheil El-Chemaly; Kevin J O'Brien; Steven D Nathan; Gerald L Weinhouse; Hilary J Goldberg; Jean M Connors; Ye Cui; Todd L Astor; Philip C Camp; Ivan O Rosas; Merte Lemma; Vladislav Speransky; Melissa A Merideth; William A Gahl; Bernadette R Gochuico Journal: PLoS One Date: 2018-03-16 Impact factor: 3.240